Amanda Nizam, MD @AmandaNizamMD Twitter profile | Pikagi

Pikagi

Amanda Nizam, MD

@AmandaNizamMD

1,826

Followers

1,190

Following

45

Media

4,010

Statuses

GU Medical Oncologist @ClevelandClinic | Bladder, kidney, & prostate Ca | Tx-related toxicity | @ASCOTECAG & @GWSMHS alum | 🌎 citizen | Views my own | COI ⬇️

Cleveland, OH (🏠 DC/VA)

https://t.co/5zF3zldBgO

Joined January 2010

Don't wanna be here? Send us removal request.

Pinned Tweet

@AmandaNizamMD

Amanda Nizam, MD

3 months

Thank you to all fellows who joined us today in the #ASCO24 @ASCOTECAG lounge for a round table discussion on Navigating the Job Search, Interviews, & Contract Negotiations! We published a comprehensive guide on this in @ASCO Connection in 2022 & hope you will find this helpful

Tweet media one

2

15

47

Last Seen Profiles

@RemyTonCto

@TheRealChiflex

@CaPtN_KuRt

@junio771391

@TTTQQQW

@narienit

@gigolo_sby007

@adam_homeblog

@stw_pdg

@alyssia

@Jingiiy

@kimdongleedong

@WindEnergyCDT

@msbartz83

@bridgertonia

@lsmydaw

@AlphaBeta268942

@Discman_

@cxsmicverge

@7Hamdani

@AgWjui

@wonhrteu

@a_staron

@SanntyAguirree_

@lordfrinton_ian

@tawasol_taif

@KITGamingElite

@Dimas4901851

@DominaAlevosia2

@MeyerSisters

@TorrentRail

@bokeplokalmalam

@frevillefarm

@PE_SPORTS_

@triplecuppped

@InMyOwnLaneeee

@AmandaNizamMD

Amanda Nizam, MD

2 years

Officially @ABIMcert board certified in Medical Oncology! Thanks to @ABIMcert ’s longitudinal knowledge assessment, after 14+ years of proctored exams, I look forward to never having to walk into a testing center again! 🎉🥳

19

2

123

@AmandaNizamMD

Amanda Nizam, MD

11 months

Thank you kindly, @ERPlimackMD & @myesmo GU committee! Much more to learn about underpinnings of toxicity w/emergence of Tx w/novel MOAs & combos across GU cancers! #ESMO23 🙏🏼 to my UNITE co-captains, @koshkin85 & @Tanjin097 , & all UNITE sites for your contributions & support!

@ERPlimackMD

Elizabeth Plimack MD

11 months

Kudos to @AmandaNizamMD @ClevelandClinic for winning 🌟Best #ESMO2023 Poster in Urothelial🌟 Your original work pooling shared data across multiple institutions to seek tissue based and clinical biomarkers of toxicity to EV in #bladdercancer is even more relevant now that most M1

Tweet media one

20

30

190

15

13

108

@AmandaNizamMD

Amanda Nizam, MD

8 months

Delighted to be an @ASCO #GU24 Featured Voice among an esteemed group of colleagues! Follow along w/ @RCCadvocate @BraunMDPhD @ShuchiGulati @sophia_kamran @RuchikaTalwarMD @DrKarineTawagi @DrYukselUrun @TiansterZhang & me for the latest insights from the 20th annual Symposium!

@ASCO

ASCO

8 months

Announcing the #GU24 Featured Voices! Follow along for a range of expert insights & join the discussion using the official hashtag: #GU24 ⤵️ @rccadvocate @BraunMDPhD @ShuchiGulati @sophia_kamran @AmandaNizamMD @RuchikaTalwarMD @drkarinetawagi @dryukselurun @TiansterZhang

Tweet media one

2

25

73

5

12

99

@AmandaNizamMD

Amanda Nizam, MD

2 years

Thank you @jamecancerdoc , @shilpaonc , & @CleClinicMD for the opportunity to stay on and join our outstanding GU Onc team! Already excited to be back in clinic and look forward to building up our clinical and translational research collaborations with @CCLRI !

@jamecancerdoc

Jame Abraham, MD, FACP

2 years

We are so excited that @AmandaNizamMD has decided to continue her career @CleClinicMD as a faculty in our GU program !! Congratulations and welcome to @ClevelandClinic #CleClinicCancer family !! @shilpaonc

Tweet media one

10

10

126

13

9

88

@AmandaNizamMD

Amanda Nizam, MD

10 months

Few things in life can extricate me from Europe 4 days earlier than originally planned, but #UromigosLive is DEFINITELY one of them!!! Excited for this mtg on the heels of a successful & groundbreaking #ESMO23 ! 🙏🏼🙏🏼 to @Uromigos for promoting junior faculty & for the opportunity!

Tweet media one

Tweet media two

Tweet media three

Tweet media four

@Uromigos

Uromigos

10 months

#UromigosLive 2023 will feature a 'Rising Stars' session this year. Promoting the next generation of GU Oncology research is part of our core mission.

Tweet media one

3

22

75

2

9

74

@AmandaNizamMD

Amanda Nizam, MD

2 years

@ClevelandClinic Hematology/Oncology Fellowship Class of 2022. Last graduation after 14 years of education & training. Could not have asked for better co-fellows to grow with over the past 3 years. To continued success & meaning in our life’s work!

Tweet media one

Tweet media two

Tweet media three

9

6

72

@AmandaNizamMD

Amanda Nizam, MD

1 year

Optimizing the safety of antibody–drug conjugates for patients with solid tumours #OncTwitter

Tweet card media

Optimizing the safety of antibody–drug conjugates for patients with solid tumours

Nature Reviews Clinical Oncology - Advances in technology have enabled the development of several novel antibody–drug conjugates (ADCs) with encouraging clinical activity in patients with...

0

12

66

@AmandaNizamMD

Amanda Nizam, MD

2 years

Off to @ASCO #GU23 ! Looking forward to exciting science and trial updates, including a strong showing from our @CleClinicMD multidisciplinary GU Onc group! Looking forward to seeing wonderful colleagues and friends!

Tweet media one

3

3

65

@AmandaNizamMD

Amanda Nizam, MD

6 months

Proud to be among the the highest-enrolling sites for this transformative trial in adv. bladder cancer! Gratitude for all of the pts who enrolled on EV-302 & all of the preceding trials over the years that helped us reach this point! Thankful for @shilpaonc 's leadership for

@jamecancerdoc

Jame Abraham, MD, FACP

6 months

Congratulations to the EV-302 investigators to this practice changing study for bladder cancer @NEJM @OncoAlert huge gratitude to the patients who enrolled in this study!! Proud of @shilpaonc @CleClinicMD @ClevelandClinic for her leadership in improving Rx of #bladdercancer

Tweet media one

7

13

72

6

6

63

@AmandaNizamMD

Amanda Nizam, MD

2 years

A pleasure to lead this guide with my #ASCOTraineeCouncil colleagues. We hope this is helpful for those starting the oncology job search! More to come on career development from @AnaVManana and me! @HemOncFellows @esinghimd @DrMMurphy @YuWeiChenMD @MadisonConces @LoganRoofMD

@AnaVManana

Ana I. Velázquez Mañana, MD, MSc, FASCO

2 years

📣 Delighted to share a guide for the #HemeOnc #OncMedTwitter #JobSearch at #ASCOConnection Great insights from #ASCOTrainee council @AmandaNizamMD @ZaidAR_MD @ramsedhom @MazieTsangMD @Joshua_Reuss @ADesaiMD Drs Espinoza & Wang 👉 @OncoAlert #MedTwitter

Tweet media one

5

27

71

2

14

63

@AmandaNizamMD

Amanda Nizam, MD

5 months

Thank you, @ASCO for naming me an Advocacy Champion in the President’s Circle at the #ASCOAdvocacySummit . I am proud to advocate for: ➡️ Action to mitigate drug shortages ➡️ Continuation of telehealth flexibilities ➡️ Robust research funding for the @NIH To get involved, visit

Tweet media one

6

3

62

@AmandaNizamMD

Amanda Nizam, MD

5 months

Thank you, @ASCO team, colleagues, & patient advocates for another successful #ASCOAdvocacySummit ! And to the inimitable @DGlaucomflecken for an empowering keynote session! Look forward to continuing to advocate locally & nationally over the next year! See you all at #ASCO24 !

Tweet media one

Tweet media two

Tweet media three

@AshleySumrallMD

Ashley Love Sumrall, MD, FACP, FASCO

@AshleySumrallMD

5 months

Sending a big thank you to @ASCOPres & the exceptional @ASCO team! Our team tackled the Hill today, and this year's #ASCOadvocacysummit was our biggest one yet! There is still time for YOU to help! Click👉🏻

Tweet media one

1

3

32

0

4

60

@AmandaNizamMD

Amanda Nizam, MD

1 year

Cruising over the Potomac into @Reagan_Airport will always be one of my favorite ✈️ landings. Great to be back in the homeland! Looking forward to seeing many old friends in DC and old and new friends at the #ASCOAdvocacySummit next week! @ASCO

7

3

57

@AmandaNizamMD

Amanda Nizam, MD

1 year

First #BCANTT23 was wonderful! Many outstanding talks by passionate & brilliant colleagues in a rapidly evolving field. Most impressed by insightful & engaged pt advocates that were central to the meeting! 🙏🏼 @BladderCancerUS team for seamlessly dovetailing science & pts’ voices!

Tweet media one

Tweet media two

Tweet media three

Tweet media four

@BladderCancerUS

Bladder Cancer Advocacy Network

@BladderCancerUS

1 year

That's a wrap! Thank you for an inspiring, informational, collegial and collaborative #BCANTT23 . It's not too late to start thinking about #BCANTT24 in San Diego August 7-9, 2024. Mark your calendars!

Tweet media one

1

8

45

2

8

52

@AmandaNizamMD

Amanda Nizam, MD

7 months

Thank you, @GUOncologyNow , for the opportunity to discuss several abstracts from #UNITE presented at @ASCO #GU24 alongside talented friends & collaborators, @koshkin85 , @DocMattCampbell , & @OAlhalabiMD . @Tanjin097 @CYJiangMD @PGrivasMDPhD @BladderCancerUS @WorldBladderCan

@GUOncologyNow

GU Oncology Now

7 months

Dive into the latest insights from the #UNITE study on targeted agents for advanced #UrothelialCarcinoma with this panel discussion from #GU24 featuring @koshkin85 , @AmandaNizamMD , @DocMattCampbell , and @OAlhalabiMD . Watch Now:

0

2

11

2

9

51

@AmandaNizamMD

Amanda Nizam, MD

8 months

💯💯💯. I consistently use the @FoxChaseCancer ASSURE RCC Prognostic Nomogram when reviewing risk of recurrence & survival with pts in the post nephrectomy setting. Adjuvant systemic Tx in select pts with resected high-risk RCC requires a careful discussion re: survival benefit

@DrKarineTawagi

Karine Tawagi MD

@DrKarineTawagi

8 months

The 🔑 slide from @PBarataMD discussion on the landscape of localized RCC post nephrectomy Impt to incorporate risk calculators when discussing risk/benefit with patients #GU24 @ASCO

Tweet media one

1

12

31

2

7

47

@AmandaNizamMD

Amanda Nizam, MD

9 months

🙏 @GUOncologyNow for the opportunity to discuss our study from UNITE examining assoc. btwn somatic alterations & EV TRAEs in pts w/aUC, presented @ #ESMO23 . @koshkin85 @Tanjin097 @PGrivasMDPhD @shilpaonc @OAlhalabiMD @arnabguonc

@GUOncologyNow

GU Oncology Now

9 months

We spoke with @AmandaNizamMD who provided an overview of her recent research on biomarkers of TRAEs associated with EV for advanced #urothelialcarcinoma , as well as results of the #UNITE study and some of its biggest takeaways. Watch now:

1

1

5

6

14

47

@AmandaNizamMD

Amanda Nizam, MD

1 year

Such a pleasure to finally meet the brilliant and wonderful Dr. @NicoleKuderer in person after so many years! Look forward to learning so much from you! Thank you for supporting so many of us young investigators! @gary_lyman #ASCO23 #OncTwitter

Tweet media one

@NicoleKuderer

Nicole Kuderer, MD, MS, FASCO 🌎🇺🇸🇪🇺🇺🇦🌏

1 year

@crisbergerot @AmandaNizamMD @ASCO @PauloBergerot @gary_lyman 🥰 So thrilled & tickled to get us all together through serendipity ✨Cris & Amanda ✨two amazing young investigators who will have a huge impact no doubt throughout their careers & help change bring toxicity considerations even more to the forefront. #WomenInMedicine @gary_lyman

1

1

6

1

7

47

@AmandaNizamMD

Amanda Nizam, MD

1 year

Thanks, @ASCO for naming me an Advocacy Champion for my continued commitment to advocating for issues affecting the #oncology community. - #FixPriorAuth & protect pt access to care - Ensure copay assistance counts towards pt out-of-pocket costs - Support fed. cancer research

Tweet media one

@ASCO

ASCO

1 year

The 2023 #ASCOAdvocacySummit Week of Action starts today‼️ Join us in urging Congress to: - #FixPriorAuth & protect pt access to care - Ensure copay assistance counts towards pt out-of-pocket costs - Support federal cancer research Take action ➡️

Tweet media one

0

16

36

3

6

45

@AmandaNizamMD

Amanda Nizam, MD

10 months

Proud to support the incomparable @DrChoueiri for @ASCO BOD! A legend in GU oncology. An unparalleled advocate, mentor, & sponsor for trainees/early career, IMGs, & @ASCO 's IMG COP. The epitome of paying it forward! Vote for this visionary leader to take @ASCO to new heights!!

Tweet media one

1

13

43

@AmandaNizamMD

Amanda Nizam, MD

1 year

Thank you, @OncoAlert , @CParkMD , & @weoncologists for the opportunity to discuss this poster from #ASCO23 . Congratulations to the @VHIO team for studying this important & clinically relevant question! @crisuarez08 Would be very interesting to examine in pts treated with ADCs.

@CParkMD

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

1 year

💡OUTSTANDING #ASCO23 @OncoAlert update on “Effect on outcomes of toxicity-related dose reduction in TKI monotherapy or TKI-IO combination therapy for adv. renal cell carcinoma”, by rising GU superstar Dr. Amanda Nizam @AmandaNizamMD . @weoncologists 👇

1

17

60

0

10

41

@AmandaNizamMD

Amanda Nizam, MD

8 months

EV-302 Subgroup Analyses presented by @MichvdHeijden #GU24 #blcsm @ASCO 🔷 EV+P improved PFS & OS regardless of cisplatin-eligibility and PD-L1 expression 🔷EV+P improved PFS & OS regardless of presence of liver, visceral, or LN metastases 🔷 EV+P improved PFS and OS across all

Tweet media one

Tweet media two

Tweet media three

Tweet media four

1

11

40

@AmandaNizamMD

Amanda Nizam, MD

2 years

This 💯💯💯! How fortunate we are to have so many brilliant & hard-working 🌟immigrants in medicine! So many examples in GU Oncology alone who have pushed their fields forward. Kudos to those who pay it forward by sponsoring & investing in these dedicated & talented physicians!

@montypal

Sumanta K. Pal, MD, FASCO

2 years

Beautifully said. I always think of this in the context of @NazliDizman , coming here from #Turkey s/p extensive training, doing 3y of rsrch at @cityofhope , then 3y more at @Yale for #residency . Couldn't have been EZ, but 👀at the productivity as she gears up for #fellowship apps!

Tweet media one

8

13

84

0

7

39

@AmandaNizamMD

Amanda Nizam, MD

10 months

FELIZ CUMPLEAÑOS a mi amiga & fellow Scorpio ♏️, @AnaVManana !! 🥳🥳 A brilliant oncologist, researcher, servant leader, mentor, advocate, and role model for myself and so many others! Eternally grateful for your friendship!!! 🥰 @NazliDizman

Tweet media one

@Florez_Lab

#FlorezLab

10 months

Happy birthday to superstar @AnaVManana ! 🍰🎂 A passionate Thoracic oncologist @UCSFCancer , #DEI advocate, & mentor per-excellence, her exceptional research has won numerous awards from @ConquerCancerFd @AACR @BioAscend ✨ The @Florez_Lab is incredibly proud of you!❣️🎉🎂🎂

Tweet media one

10

6

48

1

4

39

@AmandaNizamMD

Amanda Nizam, MD

5 months

Advocacy is a critical pillar of our roles as physicians. Thank you to @ASCO for facilitating local & national advocacy efforts to drive meaningful change for our patients with cancer. Proud of my fellow @ASCOTECAG & GU Oncology colleagues & friends who consistently advocate

0

5

38

@AmandaNizamMD

Amanda Nizam, MD

1 year

Excited to share our trainee experiences during the COVID-19 pandemic! Congrats to all of my 🌟 co-authors! It was a delight to collaborate on this! Special 🙏🏼 to @RahulBanerjeeMD for shepherding this from start to finish! Many 🙏🏼 @NicoleKuderer & @gary_lyman for your support!

@RahulBanerjeeMD

Rahul Banerjee, MD, FACP

@RahulBanerjeeMD

1 year

1/ Super proud of my co-authors! When future generations ask why our research directions suddenly changed and our protocols dramatically under-accrued as fellows from 2020-2023, we'll point to this 👇 (Not all gloom & doom: silver linings covered too!)

Tweet media one

4

19

57

3

8

39

@AmandaNizamMD

Amanda Nizam, MD

11 months

#ESMO3 2394P: Biomarkers of EV TRAEs in aUC pts on EV mono 📍UNITE (16 US sites) ➡️ 275 pts w/EV TRAEs & NGS 🔹MVA: poss. assoc. btwn MLL2 alt/cytopenias & KDM6A alt/anorexia + wt. ⬇️ ❌Overall, somatic alt status doesn’t appear to be a/w EV TRAE 🔜Add’l MVAs w/clin. biomarkers

Tweet media one

Tweet media two

1

13

38

@AmandaNizamMD

Amanda Nizam, MD

2 years

📢 #OncTwitter : Vote for Dr. @montypal for @ASCO Nominating Committee – Undesignated Member! An exceptional oncologist & human being whose inimitable vision, leadership, & commitment to trainees/junior faculty will take @ASCO to new heights! #VoteMonty

Tweet media one

1

10

37

@AmandaNizamMD

Amanda Nizam, MD

3 years

Thank you, @shilpaonc , @MosheOrnsteinMD , Dr. Diaz-Montero, & @CCLRI for your mentorship and support on this project! Excited to stay on at @ClevelandClinic to start my career in GU Oncology and look forward to prospectively studying immune-related toxicity across GU cancers!!

@shilpaonc

Shilpa Gupta

3 years

Congrats @AmandaNizamMD @MosheOrnsteinMD on leading this novel work on predictive biomarkers for irAEs! @CleClinicMD

0

3

23

0

4

36

@AmandaNizamMD

Amanda Nizam, MD

3 years

@WashProbs Like we’re living in a never-ending episode of Black Mirror

Tweet media one

0

0

34

@AmandaNizamMD

Amanda Nizam, MD

1 year

Thank you, @SenWhitehouse & @SenMarkey for supporting @ASCO and our patients with cancer! ➡️ #FixPriorAuth & protect pt access to care ➡️ Ensure copay assistance counts towards out-of-pocket costs ➡️ Support federal funding for cancer research #ASCOAdvocacySummit @asegel513

Tweet media one

Tweet media two

2

5

34

@AmandaNizamMD

Amanda Nizam, MD

10 months

Next round of the #UromigosLive Uromigos Cup! Go #TeamCleveland ! Off to a strong start!

Tweet media one

1

4

35

@AmandaNizamMD

Amanda Nizam, MD

5 months

Great news with tumor agnostic approval for pts with Tx-refractory HER2+ (IHC3+) cancers, including bladder Ca! With other HER2-directed ADCs on the horizon (e.g., DV, T-DM1), key issue will be standardization of HER2 testing in bladder Ca. @koshkin85 @Dr_Aggen @JasonBrownMDPhD

@PTarantinoMD

Paolo Tarantino

5 months

T-DXd is approved for the treatment of patients with ANY treatment-refractory HER2+ (IHC 3+) tumor, making of it the first agnostic ADC. Unlikely to be the last. Key priority: ensuring that HER2 testing is expanded across cancer types. Exciting times!

Tweet media one

5

114

310

0

6

35

@AmandaNizamMD

Amanda Nizam, MD

2 years

An outstanding, comprehensive, and forward-looking overview of MIBC from our @CleClinicMD GU leader, @shilpaonc ! Well done!! @jamecancerdoc

@DrOmarMian

Omar Mian

2 years

Dr. Shilpa Gupta discusses "Optimizing survival for patients with muscle invasive bladder cancer," from the big stage at @ASCO #GU23 @shilpaonc A great review of the current multi-disciplinary SOC as well as emerging therapies for MIBC. @CleClinicMD @ClevelandClinic

Tweet media one

Tweet media two

Tweet media three

Tweet media four

1

23

65

1

8

35

@AmandaNizamMD

Amanda Nizam, MD

2 years

Delighted to land in the “experimental arm” for what is sure to be a successful & invigorating inaugural @Uromigos Unplugged in #Nashville ! Looking forward to learning from the brightest minds in GU on the heels of #ESMO22 .🙏🏼 to @brian_rini , @tompowles1 , & organizers for the opp!

@Uromigos

Uromigos

2 years

We have a 2nd golden ticket award winner ⁦ @AmandaNizamMD ⁩ for Nashville’22 . Amanda highlights ongoing uncertainty around the agenda and faculty. ⁦⁦ @brian_rini ⁩ assures us the social events are maturing well.

0

9

35

1

3

35

@AmandaNizamMD

Amanda Nizam, MD

2 years

Looking forward to participating with wonderful colleagues, @ramsedhom , @AnaVManana , and @ADesaiMD ! #MedTwitter

@HemOncFellows

Hem-Onc Fellows Network

2 years

Join our next space: PRE #ASCO22 SPECIAL with @AmandaNizamMD @ramsedhom @AnaVManana and @ADesaiMD on Tuesday, May 24 at 6 PM ET Look out for #HOFellows team members giving stickers at the meeting. Join our newsletter #OncTrainee #OncMedEd #HemOnc

Tweet media one

0

10

34

0

6

34

@AmandaNizamMD

Amanda Nizam, MD

8 months

Truly outstanding & masterful discussion by the one & only @PBarataMD ! #GU24 Very grateful to have his & @MosheOrnsteinMD ’s expertise to call on when facing challenging clinical scenarios in RCC! #kcsm @RCCadvocate @KidneyCancer @kidneycan

@DrYukselUrun

Yüksel Ürün

8 months

Truly excellent discussion on adjuvant RCC therapy by @PBarataMD @ASCO #GU24 @OncoAlert @urotoday @DrChoueiri @yekeduz_emre @AmandaNizamMD @TiansterZhang @crisbergerot @CParkMD @cdanicas @FabioSchutz78 @OncBrothers @NazliDizman @OncoBellmunt

Tweet media one

Tweet media two

Tweet media three

Tweet media four

1

26

56

1

7

34

@AmandaNizamMD

Amanda Nizam, MD

10 months

So well deserved! Congratulations, Dr. Tannir!! @MDAndersonNews @HindRafei @NazliDizman @PavlosMsaouel @OAlhalabiMD @OncHahn @crisbergerot @montypal

@KidneyCancer

Kidney Cancer

10 months

🎉 Join us in congratulating Dr. Nizar Tannir @MDAndersonNews , who will receive the Nicholas J. Vogelzang Humanitarian Award at #IKCSNA23 . His service, mentorship, & advocacy for the #kidneycancer community is unparalleled 🧡 Read the Press Release:

Tweet media one

4

13

61

1

8

33

@AmandaNizamMD

Amanda Nizam, MD

1 year

More stellar 📝 from UNITE on indep. biomarkers assoc. w/EV outcomes & biomarkers of SG response & efficacy of SG post-EV! Outstanding job by 🤩 future Dr. @Tanjin097 , who is applying to med school this year! Exceptional & incomparable mentor @koshkin85 here in spirit! 😃 #ASCO23

Tweet media one

Tweet media two

Tweet media three

Tweet media four

@Tanjin097

Tanya Jindal

1 year

We found an independent association btwn several molecular biomarkers & EV outcomes in pts with aUC: 🟢 ERBB2 alterations: ⬆️ OS 🟢 KDM6A alterations: ⬆️ OS 🔴 PIK3CA alterations: ⬇️ ORR 🔴 High PD-L1 expression: ⬇️ OS & ⬇️ORR 🔴 Low TMB: ⬇️ OS See poster👇🏼 #ASCO2023 1/2

Tweet media one

Tweet media two

Tweet media three

Tweet media four

2

13

27

1

13

32

@AmandaNizamMD

Amanda Nizam, MD

11 months

En route to Madrid for #ESMO23 ! ✈️ Looking forward to a remarkable #ESMO23 for the GU field and to seeing many colleagues & friends! Buen viaje! @koshkin85 @PGrivasMDPhD @shilpaonc @montypal @ReginaBarCar @BenMironMD @rafee_talukder @KimAllman4 @AnaVManana @Joshua_Reuss @Uromigos

1

4

31

@AmandaNizamMD

Amanda Nizam, MD

4 months

THIS is the definition of tenacity! Congratulations to the brilliant @LauraBukavinaMD & her team for continuing to lead the way in gut microbiome research in bladder cancer! Much more to learn about the role of the gut microbiome in cancer pathogenesis & anti-tumor response as

@LauraBukavinaMD

Laura Bukavina

@LauraBukavinaMD

4 months

It is finally out.!!. 🔬 Our latest study studies how the gut microbiome (GM) may influence chemo response in bladder cancer patients. #BladderCancer #Microbiome published @CRC_AACR . What an incredible effort by @caseccc @FoxChaseCancer @CancerResearch

Tweet media one

2

20

105

3

3

31

@AmandaNizamMD

Amanda Nizam, MD

1 year

💯💯💯 Thank you, @ASCO staff, for your tireless commitment to the oncology community & our patients with cancer! A successful and empowering #ASCOAdvocacySummit which was seamless thanks to you all! #OncTwitter

@IshwariaMD

Ishwaria Subbiah, MD MS FASCO

1 year

THANK YOU, @ASCO staff! Incredibly grateful and thankful for your meticulous attention to every detail at #ASCOAdvocacySummit , for taking such great care of us all, and for empowering each of us to be ambassadors for our patients and peers! 📸 of our staff rockstars in action!

Tweet media one

Tweet media two

Tweet media three

Tweet media four

4

10

72

1

6

30

@AmandaNizamMD

Amanda Nizam, MD

3 months

Thank you, @CParkMD for your infectious optimism, collaborative spirit, & for being a truly generous sponsor for many of us junior investigators! You truly pay it forward by connecting, educating, & mentoring so many in the oncology world! Proud to be your friend!! #ASCO24

@CParkMD

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

3 months

⭐️Mentor and Mentee Moment at #ASCO24 . Loved learning from Dr. Jame Abraham as his heme onc fellow. Now as a mentor I get to help one of the brightest young minds. #Mentorship #PayItForward @jamecancerdoc @YLeyfman @PGrivasMDPhD @shilpaonc @montypal @neerajaiims

Tweet media one

2

7

44

3

6

29

@AmandaNizamMD

Amanda Nizam, MD

10 months

Congratulations, Dr. @KimrynRathmell !! So well deserved! So exciting to have two preeminent women physician-scientists in oncology who have supported so many early career investigators leading the @theNCI and @NIH ! @ASCO @KidneyCancer @kidneycan #womeninSTEM

@christine_lovly

Christine Lovly, MD, PhD

@christine_lovly

10 months

⬇️ The outstanding national leadership for healthcare + cancer care in the USA 🇺🇸. What an inspiring day + proud moment for #WomeninMedicine #WomeninSTEM . ⁦ @NIH ⁩ ⁦ @theNCI ⁩

Tweet media one

6

46

237

0

1

28

@AmandaNizamMD

Amanda Nizam, MD

7 months

#RMS @ReneeSaliby is an incredibly thoughtful, brilliant, hard-working, & kind person! And already a force in #RCC !!! Can’t wait to see which lucky IM residency program will get her! @ASCOTECAG @IMG_Oncologists

@DrChoueiri

Toni Choueiri, MD

8 months

She is a super star and applying for IM residency! Please take note of RMS @ReneeSaliby ! @DanaFarber_GU

Tweet media one

2

20

86

1

4

27

@AmandaNizamMD

Amanda Nizam, MD

3 months

Thank you for attending & for all of your insightful questions! We were very happy to chat with residents, med students, and high school students! The future is bright! @ASCOTECAG #ASCO24

@AviHarisingani

Avi Harisingani, MD

@AviHarisingani

3 months

An amazing session with @AmandaNizamMD @Latinamd @neerajaiims providing us with their unique perspectives and insights on academic practice in oncology! #ASCO24

Tweet media one

0

1

11

0

6

27

@AmandaNizamMD

Amanda Nizam, MD

1 year

💯💯💯. @DrChoueiri , @montypal , @neerajaiims , @PGrivasMDPhD , #NizarTannir , and others consistently pay it forward in supporting the next generation! Proud to see @NazliDizman & @ZiadBakouny doing this as well with their @ASCO IMG community of practice! @IMG_Oncologists

@thenasheffect

Rafeh Naqash, MD

1 year

@DrChoueiri @ZiadBakouny @sarahaboualaiwi @TalalZarif1 @adib_elio @DanaFarber_GU @VanAllenLab @BrighamMedRes @YaleIMed @MSKCancerCenter @YaleCardiology @HarvardRadOnc @YaleMedPSTP Congratulations to @ZiadBakouny @sarahaboualaiwi and @TalalZarif1 @adib_elio , future leaders, movers, shakers and disrupters (In a good way) in thier fields. This is how mentors like @DrChoueiri help shape the next gen and support the cause of #IMGs @IMG_Oncologists 👏 BRAVO

2

0

19

1

3

27

@AmandaNizamMD

Amanda Nizam, MD

8 months

Long anticipated results from the @ALLIANCE_org A031501 AMBASSADOR Phase 3 trial of adjuvant pembrolizumab vs. observation in MIBC presented by the visionary @apolo_andrea 📄 Abs. LBA531 📅 Fri. 1/26/2024 ⏲️ 4:15pm-5:45pm PST 📍 Level 3 #GU24 @BladderCancerUS @WorldBladderCan

@nciccr_gmb

NCI CCR GU Malignancies

8 months

This Friday at @asco #GU24 Dr. Andrea Apolo @apolo_andrea @nciccr_gmb @NCIResearchCtr will present the results from the phase 3 AMBASSADOR of adjuvant Pembro in urothelial carcinoma @ALLIANCE_org

Tweet media one

Tweet media two

3

27

66

2

9

26

@AmandaNizamMD

Amanda Nizam, MD

1 year

Congrats to my sister friend, @ZeynepZengin , and @LuisMezaco for matching at their #1 program! You will do great!! 🥳🥳🎉 Congratulations also to @montypal for outstanding mentorship and a legacy of nurturing brilliant and talented IMGs! #MatchDay

@montypal

Sumanta K. Pal, MD, FASCO

1 year

Words cannot express how proud I am of my @cityofhope fellows @ZeynepZengin 🇹🇷 & @LuisMezaco 🇵🇪, who matched at @YaleIMed just moments ago (yes, I am wearing a #YaleDad hat!). Their hard work & dedication over 3y has paid off. Huge thanks to @NazliDizman for blazing this trail &

Tweet media one

36

42

277

2

2

25

@AmandaNizamMD

Amanda Nizam, MD

2 years

Congratulations to Prof. @tompowles1 , Dr. @brian_rini , & the entire Mashup Media team for an extraordinarily successful & invigorating inaugural #UromigosLive ! An unparalleled format with brilliant panelists! Very grateful to attend as one of the golden 🎟 winners! @GUOncologyNow

@Uromigos

Uromigos

2 years

Golden ticket winner @AmandaNizamMD summarises thr discussion around treatment choices for hormone sensitive prostate cancer #nashville22 #UromigosLive

0

4

18

1

6

24

@AmandaNizamMD

Amanda Nizam, MD

1 year

This👇🏼. Always insightful and meaningful contributions from Dr. @AnaVManana to address inequities in health care. A true role model in “walking the walk” through her passionate work and advocacy! Proud of my admirable friend! #ASCO23

@KVanLoonMD

Katherine Van Loon, MD, MPH

1 year

@AnaVManana @UCSFCancer offers practical advice for clinicians to eliminate systemic racism in oncology. “Identify it, Call it, Act on it.” 🫶🏻

Tweet media one

Tweet media two

0

5

21

1

8

24

@AmandaNizamMD

Amanda Nizam, MD

8 months

Find awesome, brilliant friends who come to support your early AM talks! 🤩 🥰 @ShuchiGulati @NazliDizman @bergsa83

@ShuchiGulati

Shuchi Gulati MD

8 months

‼️✴️ Ready or not here we go! Day 2 #GU24 for #urothelial carcinoma! ‼️ Excitedly waiting for rockstar @AmandaNizamMD ’s stellar oral talk!

Tweet media one

Tweet media two

1

5

19

2

4

24

@AmandaNizamMD

Amanda Nizam, MD

2 years

Well said from one of Dr. @montypal ’s 🌟 mentees, Dr. @NazliDizman . Always paying it forward, his inimitable vision, leadership, & talent will catalyze ASCO’s growth & impact in the years to come! 🙏🏼 for your dedication to @ASCO & esp. the next gen of investigators! #VoteMonty

@NazliDizman

Nazli Dizman

2 years

👏Thrilled to support @montypal for the nominating committee position in the @ASCO elections! An outstanding physician/researcher/advocate, amazing mentor & visionary leader committed to serving patients & @ASCO 🙏 📅Voting opens on 11/2 #VoteMonty #VoteASCO #OncTwitter

Tweet media one

Tweet media two

Tweet media three

1

15

38

0

7

24

@AmandaNizamMD

Amanda Nizam, MD

1 year

@ASCOTECAG G.O.A.Ts! 🌟🌟🌟You’re doing an outstanding job, @FernandoDiazMD1 !! We are so fortunate to have you as our President! It’ll be another great year for @ASCOTECAG ! @ASCO #ASCO23

@FernandoDiazMD1

Fernando Diaz, MD

@FernandoDiazMD1

1 year

Truly thankful to @ramsedhom 's leadership guiding us to a successful year on the @ASCOTECAG along with @AnaVManana 's unconditional support. I have huge shoes to fill this year as the leader of the #TECAG . @ASCO #ASCO23 @HemOncFellows @LatinxOncology

Tweet media one

Tweet media two

7

6

47

1

3

23

@AmandaNizamMD

Amanda Nizam, MD

5 months

Congratulations & well deserved to a brilliant physician-scientist and great human who has consistently pushed the bladder cancer field forward! @BCAN_Research @BladderCancerUS @WorldBladderCan @LauraBukavinaMD @PGrivasMDPhD @koshkin85

@FaltasLab

Dr. Bishoy M. Faltas

5 months

1/ Thrilled to take on this new role as Chief Research Officer of the Englander Institute for Precision Medicine @WCMEnglanderIPM @WeillCornell

63

22

282

0

2

23

@AmandaNizamMD

Amanda Nizam, MD

1 year

Thank you, @koshkin85 for your mentorship and support!

@koshkin85

Vadim Koshkin MD

1 year

Tireless & talented @AmandaNizamMD @ClevelandClinic with a great talk at #AIBCCR meeting reviewing therapy sequencing in met #BladderCancer Distilled a lot of great data in this talk with biomarker and sequencing data from UNITE database and much else! @BladderCancerUS

Tweet media one

Tweet media two

Tweet media three

Tweet media four

2

6

35

0

0

22

@AmandaNizamMD

Amanda Nizam, MD

2 years

So proud of my dear friend and co-fellow, Dr. @MadisonConces ! Oral presentation at #WCGIC2022 as she rounds out her second year of fellowship! With outstanding mentorship by the wonderful @smitha42 ! Keep shining!🌟 #DreamTeam @CleClinicMD

@smitha42

Smitha Krishnamurthi

2 years

So proud of rockstar fellow @MadisonConces for her work showing our patients with early-onset, compared to average-onset, rectal cancer have more nausea with chemo in TNT. 🙏🏾 all co-authors! #WCGIC2022 @CleClinicNews @sujataCLE @EmreGorgunMD @DavidLiskaMD @aakonc @SKamath_MD

Tweet media one

Tweet media two

5

15

69

2

0

22

@AmandaNizamMD

Amanda Nizam, MD

2 years

Outstanding presentation from🌟🌟 @Tanjin097 on biomarkers of response to EV from the UNITE study! Med schools - watch out for this 🌟 applicant this year! 👏🏼 to the UNITE team led by 🌟 mentor, @koshkin85 ! Thanks for including us @ CCF! More to come from this great collab! #gu23

Tweet media one

Tweet media two

@JasonBrownMDPhD

Jason Brown

@JasonBrownMDPhD

2 years

Analysis of retrospective UNITE study data shows ⬇️PFS with CDKN2A/B and MTAP alterations and ⬆️ OS with high TMB. ⬆️ ORR with TSC1 and ERBB2 alterations. Great work Tanya Jindal! @koshkin85 . Looking forward to getting this study open at @UHhospitals

Tweet media one

Tweet media two

Tweet media three

Tweet media four

1

5

15

0

7

22

@AmandaNizamMD

Amanda Nizam, MD

2 years

No @ASCO conference is complete w/o an outstanding showing from #TeamPal ! Incredibly impressed by all of the presentations from undergraduates at #GU23 ! The future of oncology is bright! 🙏🏼 to the many amazing mentors in our field! Special 🙏🏼 to @arafflemd for 4 takes of 📸 #1 😂

Tweet media one

Tweet media two

Tweet media three

@montypal

Sumanta K. Pal, MD, FASCO

2 years

Gotta say that #GU23 was one of my fav @ASCO mtgs yet, with dear friends @neerajaiims & @KidneyCancerDoc flanking the agenda w practice-changing studies in #prostatecancer & #kidneycancer , respectively. Was also super proud of my incredible team ( @EbrahimiHedyeh @NazliDizman

Tweet media one

Tweet media two

Tweet media three

Tweet media four

0

12

78

0

5

22

@AmandaNizamMD

Amanda Nizam, MD

1 year

What an exciting time for patients, advocates, & providers in GU oncology! The power of science, collaboration, & persistence to get these trials over the finish line! Looking forward to attending my first @myESMO #ESMO23 & presenting our work on EV TRAEs! @koshkin85 @Tanjin097

@montypal

Sumanta K. Pal, MD, FASCO

1 year

The number of key trials in #genitourinary cancers being presented at #ESMO23 is unprecedented. Looking fwd to seeing results of #LITESPARK -003, -005 & -013 presented by @DrChoueiri , @AlbigesL & @neerajaiims in a SINGLE SESSION! Also #RENOTORCH , a study I was admittedly not

Tweet media one

Tweet media two

Tweet media three

1

30

88

1

4

22

@AmandaNizamMD

Amanda Nizam, MD

2 years

🙏🏼 to @AnaVManana for her outstanding leadership of the @ASCO TECAG! It’s been so fun working w/colleagues & @ASCO staff! I look forward to continuing to serve on TECAG under the leadership of the brilliant @ramsedhom ! Stay tuned for more from all of us at #ASCO22 & this summer!

@AnaVManana

Ana I. Velázquez Mañana, MD, MSc, FASCO

2 years

Excited to welcome & pass the baton to @ramsedhom as new Chair of #ASCOTrainee council 2022-2023 🎉 It’s been an amazing year working w/ colleagues to promote #oncology education & trainee career development Looking forward to seeing you all at #ASCO22 & welcome our new members!

Tweet media one

11

10

84

2

1

22

@AmandaNizamMD

Amanda Nizam, MD

2 years

Midterms may be over, but ASCO elections are still going on! Don’t forget to vote for a truly inspiring & visionary leader, Dr. @montypal , for @ASCO Nominating Committee - Undesignated Member! The future of oncology & @ASCO is bright!🌟 @AnaVManana @NazliDizman @crisbergerot

@AmandaNizamMD

Amanda Nizam, MD

2 years

📢 #OncTwitter : Vote for Dr. @montypal for @ASCO Nominating Committee – Undesignated Member! An exceptional oncologist & human being whose inimitable vision, leadership, & commitment to trainees/junior faculty will take @ASCO to new heights! #VoteMonty

Tweet media one

1

10

37

0

5

22

@AmandaNizamMD

Amanda Nizam, MD

10 months

Thank you, @PGrivasMDPhD , @morr316 , @TDorffOnc , @DrRosenbergMSK , @neerajaiims , @DrChoueiri , @DrRanaMcKay , @shilpaonc , @brian_rini , @tompowles1 , et al. for valuable feedback on all of our concepts and for supporting early career investigators!

@PGrivasMDPhD

Petros Grivas

10 months

Agree: we indeed love our rising stars @PBarataMD @bergsa83 @AmandaNizamMD @anis_a_hamid @DrKarineTawagi their concepts were fantastic & generated great discussion! @Uromigos #UromigosLive @GUOncologyNow @MdMashup @OncoAlert @morr316 @neerajaiims @TDorffOnc @DrChoueiri @montypal

Tweet media one

Tweet media two

Tweet media three

Tweet media four

0

7

26

0

3

21

@AmandaNizamMD

Amanda Nizam, MD

9 months

Congratulations to our #MMsm superstar, @DimaDanai !!! @ccfhemonc @jamecancerdoc @RahulBanerjeeMD @rajshekharucms

@khouri_jack

Jack Khouri

9 months

So proud of our rockstar @CleClinicMD fellow @DimaDanai for a stellar presentation on real world teclistamab in #mmsm . Similar responses to clinical trial although many of our patients would have been ineligible!

Tweet media one

Tweet media two

2

14

49

1

4

21

@AmandaNizamMD

Amanda Nizam, MD

1 year

Outstanding & comprehensive review on ADC-related toxicities. Very important focus of study as ADC use expands across solid tumors. Need to optimize tox management to allow pts maximal Tx benefit & preserve QoL. @koshkin85 @Tanjin097 @charlesbnguyen @NicoleKuderer #OncTwitter

@PTarantinoMD

Paolo Tarantino

1 year

Truly impressed by the interest generated by our review on optimizing the safety of ADCs, ranked 1st among articles of the same age on @NatRevClinOncol ! ✳️ You can now use this link to read the article without paywall 👉

Tweet media one

7

64

246

0

2

21

@AmandaNizamMD

Amanda Nizam, MD

1 year

🙏🏼, @PGrivasMDPhD , & to the Leo & Anne Albert Institute for the opportunity to discuss how to optimally sequence systemic Tx in mUC in a very dynamic landscape! Looking forward to EV302 & CM901 data! 🙏🏼 to @JasonBrownMDPhD @Tanjin097 @OAlhalabiMD @NazliDizman for help practicing!

@PGrivasMDPhD

Petros Grivas

1 year

Impressive talk by @AmandaNizamMD on rapidly evolving systemic Tx in advanced urothelial Ca & the quest of optimal sequence! Awaiting to see data from EV302 & CM901 trials! Also Interesting data by UNITE study! @Uromigos @shilpaonc @koshkin85 @MattMilowsky @MattGalsky @Tanjin097

Tweet media one

Tweet media two

Tweet media three

Tweet media four

3

10

46

1

2

21

@AmandaNizamMD

Amanda Nizam, MD

2 years

Look forward to eventually opening the well designed, biomarker-based OPTIC trial for 1L mRCC @ClevelandClinic @MosheOrnsteinMD @shilpaonc @ChrisWeeMD @brian_rini @katy_beckermann @DrScottHaake @UromigosLive #kidneycancer

@Uromigos

Uromigos

2 years

#UromigosLive #kidneycancer @Twitter poll analysis by @montypal asking which is the most exciting trial? Majority voted for biomarker based OPTIC trial led by @brian_rini @VUMC_Cancer

Tweet media one

Tweet media two

0

3

14

0

7

20

@AmandaNizamMD

Amanda Nizam, MD

3 years

What an invigorating #GU22 ! Nothing more inspiring than reuniting in person to witness the myriad of ways our brilliant colleagues continue to push the field forward in the multi-disciplinary care of pts with GU cancers. 1/4

@davisa20

Mandy Davis Aitken

3 years

#GU22 ended with a beautiful sunset! Thanks to the faculty, committee members, staff, vendors and attendees that made it great. Looking forward to seeing you all again June 3-7 in Chicago for #ASCO22 . Learn more at

Tweet media one

0

11

54

1

1

20

@AmandaNizamMD

Amanda Nizam, MD

2 years

Thank you to the entire @ASCO community - especially staff, volunteers, and organizers - for a wonderful #ASCO22 meeting! It was such a joy to reunite in person for the first time in 3 years! Until the next conference! Safe travels to all!

@davisa20

Mandy Davis Aitken

2 years

I find myself at a loss for words as the meeting ends but I am so thankful for the amazing community of ASCO staff, vendors, faculty and volunteers that made #ASCO22 possible. Watching the ASCO community reunite was a joy. Looking forward to seeing you all again at #ASCO23

Tweet media one

6

5

71

0

0

20

@AmandaNizamMD

Amanda Nizam, MD

2 years

🚨REMINDER: Trainees and Early Career faculty in #HemeOnc - join @ASCO and Dr. @IlanaSchlam for a webinar session on Effective Grant Writing! @HemOncFellows #MedEd #MedTwitter TOMORROW, August 26th 10:00am-11:00am EST Register👇🏼

@AnaVManana

Ana I. Velázquez Mañana, MD, MSc, FASCO

2 years

📣 #HemeOnc trainees & early career register today for @ASCO #GrantWriting Webinar 📅August 26 ⏲️10am EST w/ Dr. @IlanaSchlam & Dr. Sogol Mostoufi-Moab 🔗 @HemOncFellows @ramsedhom @thenasheffect @AmandaNizamMD @ADesaiMD @jacobadashek @ReginaBarCar

3

20

39

0

3

19

@AmandaNizamMD

Amanda Nizam, MD

8 months

Much gratitude to super mentor & collaborator, @koshkin85 , brilliant & creative UNITE co-pilot @Tanjin097 , & all UNITE collaborators! Grateful to be a part of #UNITE and look forward to ongoing & future UNITE studies to help answer difficult ❓in a rapidly evolving Tx landscape

@koshkin85

Vadim Koshkin MD

8 months

Amazing to work with @AmandaNizamMD a true 🌟on this and other #Unite projects. Great job presenting EV outcomes in pts after avelumab maintenance @ASCO #GU24 @shilpaonc @Tanjin097 @OAlhalabiMD @sonpavde @DocMattCampbell @PGrivasMDPhD @CParkMD @GUOncologyNow @urotoday @Uromigos

Tweet media one

Tweet media two

Tweet media three

Tweet media four

0

9

38

0

3

19

@AmandaNizamMD

Amanda Nizam, MD

1 year

Fantastic presentation by @EbrahimiHedyeh on more intriguing data from IO-based systemic therapy combinations +/- CBM-588 in mRCC! Congratulations!! @montypal @NazliDizman @AbhiTrip87 @kcCURE @KidneyCancer @kidneycan #OncTwitter #ASCO23

@EvanHallMD

Evan Hall

1 year

Data from nivo/Cabo +/- CBM-588 in metastatic #kidneycancer presented by @EbrahimiHedyeh @AbhiTrip87 @montypal @CityofHope_GU building on prior Ph 1 study combining with ipi/nivo. Allowed papillary histology. Excellent, clear presentation.

Tweet media one

Tweet media two

Tweet media three

Tweet media four

1

7

13

0

11

19

@AmandaNizamMD

Amanda Nizam, MD

9 months

🚨 REMINDER: Last chance to 🗳️ in @ASCO Elections! ⏲️ DEADLINE: Monday, Dec. 4th at 3:00PM EST Proud to support: 🌟The incomparable GU Oncology legend & mentor, @DrChoueiri ! 🌟Our indefatigable #ASCOAdvocacy leader & past @ASCO Gov't Relations Committee Chair, @DrJasonWestin !

Tweet media one

Tweet media two

@ASCO

ASCO

10 months

Voting for the ASCO Election is now open. All eligible members are encouraged to cast their ballots. 🗳️ Vote now:

Tweet media one

0

30

47

2

10

19

@AmandaNizamMD

Amanda Nizam, MD

8 months

Incredibly important personalized #PCa screening recommendations for Black men from Dr. #IslaGarraway @dgsomucla & @PCFnews @ASCO #GU24 📄 Abs. 264 / Poster K21 🔷 Poster Session A: PCa 📆 Thurs. 1/25/2024 ⏱️ 11:30am - 1:00pm PST 📍Level 1, West Hall

Tweet media one

@ASCO

ASCO

8 months

Breaking news from #GU24 : @PCFNews recommends lowering baseline PSA testing to 40 to 45 years in Black men, followed by regular screening intervals until age 70, to reduce #prostatecancer mortality w/ increasing overdiagnosis: #ASCODailyNews #pcsm #gucsm

Tweet media one

0

8

22

0

4

19

@AmandaNizamMD

Amanda Nizam, MD

8 months

I remember being so impressed by @AJangMD ’s proactiveness & curiosity at #GU22 ! Continue to be impressed to this day! Have so enjoyed watching this rising ⭐️ & genuinely kind human continue to soar with his excellent work under the outstanding mentorship of @PBarataMD ! #GU24

@AJangMD

Albert Jang, MD

8 months

Finally got a pic with a ⭐ of @ASCO #GU24 ! I remember when @koshkin85 introduced us at my first #GU22 and she was my first advisor on the fellowship interview trail & #CLE @Tanjin097 @shilpaonc @JasonBrownMDPhD @PBarataMD @caseccc @ccfhemonc @cwruhemeonc @TwoOncDocs @Uromigos

Tweet media one

0

4

28

2

1

19

@AmandaNizamMD

Amanda Nizam, MD

6 months

Congratulations to 🌟 #UNITE co-pilot @Tanjin097 on winning Best Poster at #ESMOTAT24 !! Important work from #UNITE examining characteristics of pts with aUC with primary resistance to EV. Need to understand biological mechanisms differentiating pts with CR vs. PD to frontline

@Tanjin097

Tanya Jindal

7 months

In UNITE, we saw patients with aUC who experienced primary PD on EV, had more CDKN2B alterations and were more likely to receive platinum-based chemo as tx immediately prior to EV compared to those without primary PD #ESMOTAT @koshkin85 @PGrivasMDPhD @AmandaNizamMD @urotoday

Tweet media one

1

4

19

1

4

17

@AmandaNizamMD

Amanda Nizam, MD

1 year

🙏🏼 @kaydaustin , & all pt advocates for embracing your powerful voices! We learn from & are driven by our pts in our clinical & research efforts. It is our prerogative as physicians to embrace our role as advocates in partnership WITH our pts. We cannot drive progress alone. @ASCO

@kaydaustin

Katie Coleman

1 year

What's it like being a once shy and very introverted patient advocate at the largest oncology conference? A thread on #ASCO23 from a patient perspective and a heartfelt thank you to those who truly embodied ASCO's theme this year - Partnering with Patients 👇

Tweet media one

2

11

81

2

3

18

@AmandaNizamMD

Amanda Nizam, MD

9 months

Very proud of colleagues spearheading this effort! @ASCO #ASCOAdvocacy has been a staunch advocate for removing barriers to telehealth coverage. Ask your lawmakers to support: 📜S.2016/H.R.4189: CONNECT for Health Act of 2023

Tweet card media

Text - S.2016 - 118th Congress (2023-2024): CONNECT for Health Act of 2023

Text for S.2016 - 118th Congress (2023-2024): CONNECT for Health Act of 2023

www.congress.gov

@seanmmcbride

Sean McBride

9 months

1/n Today we've started a legal campaign to break down state telehealth licensure restrictions. The fact that MD specialists, already licensed in their home state, must also obtain full licensure in every state where their potential patients reside violates the US Constitution🧵

8

31

192

0

4

17

@AmandaNizamMD

Amanda Nizam, MD

6 months

Congratulations to the outstanding, @ggebraelmd !! So happy you will train in such a wonderful program and continue to work with the legendary @neerajaiims ! #ProudLebanese @ReneeSaliby @nsayeghmd

@ggebraelmd

Georges Gebrael

6 months

Unreal feeling! I am honored to match @UofUInternalMed Wouldn't be possible without the tremendous support from my family, friends, colleagues & specially my mentors and team who believed in me @neerajaiims @umangtalking @maughanonc @montypal Excited for what's ahead #Match2024

Tweet media one

62

12

236

1

0

17

@AmandaNizamMD

Amanda Nizam, MD

3 months

Incredibly important for PCa & other malignancies. Improved systemic therapies & patient survival necessitate the development of risk models for long-term treatment-related toxicities. @crisbergerot @thenasheffect @PavlosMsaouel @OAlhalabiMD @LauraBukavinaMD

@OncHahn

Andy Hahn

3 months

Check out our editorial on CV risk in men with prostate cancer treated with ADT @pcan_journal We discuss the need to develop risk models specific to men with PCa and to better understand the biologic determinants of toxicity @aaparicioMD @MDAndersonNews

Tweet media one

2

20

48

0

6

17

@AmandaNizamMD

Amanda Nizam, MD

6 months

Congratulations to the incomparable rockstar, #RMS !!! 🤩🤩🤩 So proud of you and so well deserved! What a GU powerhouse at Yale!! @DrChoueiri @BraunMDPhD

@ReneeSaliby

Renee Maria Saliby

6 months

⭐️Over the moon to have matched at @YaleIMed I cannot wait to experience and hopefully live up to: "As good as any, nicer than most" @MarkDSiegel1 (I can finally use this GIF! hope I do better than Rory!)

Tweet media one

Tweet media two

Tweet media three

68

21

305

1

1

17

@AmandaNizamMD

Amanda Nizam, MD

8 months

Outstanding presentation, as always, by the #PCa master, @neerajaiims ! Important context for CONTACT-2 findings: Cabo-atezo vs. 2nd NHT was studied in a highly selected population of pts with measurable extrapelvic soft tissue metastasis. #GU24 @DrYukselUrun @TiansterZhang

@DrYukselUrun

Yüksel Ürün

8 months

@neerajaiims excellent presentation CONTACT-2 ⏺️cabo-atezo better than NHT ⏺️role of adding atezo?? ⏺️Control arm? AR switch? @ASCO #GU24 @OncoAlert @urotoday @oncodaily @DrChoueiri @yekeduz_emre @sophia_kamran @BraunMDPhD @AmandaNizamMD @TiansterZhang @RCCadvocate

Tweet media one

Tweet media two

Tweet media three

Tweet media four

0

13

26

1

5

17

@AmandaNizamMD

Amanda Nizam, MD

2 years

Very comprehensive & well-written review on an important & often understudied topic. Will become even more important to study with the rapid development of novel therapeutics & Tx combinations. Congratulations to the authors! @NicoleKuderer @ADesaiMD @maryam_lustberg @gary_lyman

@VivekSubbiah

Vivek Subbiah, MD

2 years

⭐️ The burden of chemotherapy-toxicity remains high & is associated with considerable morbidity, mortality and costs. Comprehensive review on management of acute chemotherapy related toxicities in patients with cancer @NatRevClinOncol

Tweet media one

3

88

258

1

5

17

@AmandaNizamMD

Amanda Nizam, MD

2 years

One more picture of @ClevelandClinic Heme/Onc Fellowship Class of 2022 for old times’ sake!

Tweet media one

1

0

15

@AmandaNizamMD

Amanda Nizam, MD

1 year

This is so terribly sad 🥺. Had the pleasure of sitting w/ @bodagetta & his now hubby @Uromigos Live 2022 & have loved following him on Twitter since. What a remarkable advocate for pts w/RCC. 🙏🏼 for sharing your journey & helping so many w/your kindness & humor. We’ll miss you…

@kaydaustin

Katie Coleman

1 year

Heartbroken by the news of Michael’s passing. Michael, you will be deeply missed and I’ll think of you and your waiting room floor series as I sit in every waiting room lobby, silently judging the patterns on the flooring. I hate this disease 😢🧡 Going to miss you friend

35

8

303

0

2

17

@AmandaNizamMD

Amanda Nizam, MD

2 years

Thank you to all who have helped shape us - countless mentors near & far, our awesome PD, Dr. McNamara, & APDs, Dr. @MeganKruseMD , Dr. Shapiro, & Dr. Mazzoni. Look forward to starting the next chapter at @CleClinicMD with our outstanding GU Oncology group under @shilpaonc ’s helm!

2

0

17

@AmandaNizamMD

Amanda Nizam, MD

8 months

Tune in to this timely & informative session led by @shilpaonc & @DrJohnSfakianos ! See ⬇️. With approval of EV/pembro in aUC, adjuvant nivo, & ongoing perioperative trials investigating IO-based regimens,❓re: IO sequencing, rechallenge, & pairing will arise frequently. #GU24

@shilpaonc

Shilpa Gupta

8 months

#GU24 @ASCO Looking forward to co-chairing an exciting session around key Qs in IO sequencing, pairing & re-challenging w/ @DrJohnSfakianos An all 🌟line-up of speakers!! @WilliamKimMD @montypal #Peter O’Donnell #Dan Geynisman 👉Fri, Jan 26 2.30 PM PST

Tweet media one

Tweet media two

Tweet media three

Tweet media four

1

19

67

0

5

17

@AmandaNizamMD

Amanda Nizam, MD

3 years

Thank you, @TowerLightsCLE for demonstrating CLE’s support for Ukraine 🇺🇦 📸: @GabeWasylko

@GabeWasylko

Gabe Wasylko

3 years

Saturday Skylines in Cleveland, OH 🇺🇦

Tweet media one

14

83

1K

1

0

16

@AmandaNizamMD

Amanda Nizam, MD

3 months

Safe travels and see you soon!!! ✈️😃 #ASCO24

@AnaVManana

Ana I. Velázquez Mañana, MD, MSc, FASCO

3 months

☀️ We are ready for #ASCO24 ✈️ See you soon #Chicago ! No issues with overhead space over here… this year I’m subscribed to @ShrutiPatelMD team checked (overweight) bag 🤭 @COlazagasti @DrSteveMartin @lungoncdoc @NarjustFlorezMD

Tweet media one

4

5

51

0

1

16

@AmandaNizamMD

Amanda Nizam, MD

3 months

Always knew @thenasheffect had some secret superpower!! #visaninja 🦹🏻‍♂️ What a testament to your tenacity & dedication to academia! Even more commendable is his commitment to paying it forward with his mentorship & collaboration with other exceptional IMGs! @TalalZarif1

@jamecancerdoc

Jame Abraham, MD, FACP

3 months

I have been on every visa…F1, J-1 alien 😀 truly inspiring journey of an amazingly successful young academic oncologist ⁦ @thenasheffect ⁩ !! So proud of you !! ⁦ @IMG_Oncologists ⁩ ⁦ @ASCO ⁩ #ASCO24

Tweet media one

Tweet media two

Tweet media three

3

8

44

0

2

16

@AmandaNizamMD

Amanda Nizam, MD

1 year

So great to see you again, @crisbergerot , @PauloBergerot , and Miss Anne!! Look forward to seeing you all again soon! 🥰

@crisbergerot

Cristiane D Bergerot

1 year

Yay! I'm thrilled that it works perfectly 🤩 It's truly a pleasure to meet both of you, @NicoleKuderer & @AmandaNizamMD @ASCO #ASCO23 @PauloBergerot

Tweet media one

1

3

40

0

4

16

@AmandaNizamMD

Amanda Nizam, MD

3 months

Thank you, @ASCO team for a stellar & whirlwind #ASCO24 ! We’re especially grateful for the new @ASCOTECAG lounge this year - a resounding success for networking & career development guidance! @AnaVManana @NazliDizman @Latinamd @neerajaiims

@Noha_Soror

Noha N. Soror, MD, MSc. 𓂀

3 months

We are very proud of this year's #TECLounge with all the new amenities and superb educational sessions. We had great time learning, having fun and connecting with friends. Thank you @ASCO , @asco staff and @FernandoDiazMD1 for the recognition and all the hard work. @ASCOTECAG

Tweet media one

Tweet media two

Tweet media three

Tweet media four

0

13

38

0

2

16

@AmandaNizamMD

Amanda Nizam, MD

2 years

This is an excellent point. Let’s bring this up in our next @ASCO TECAG meeting, @ramsedhom @AnaVManana .

@koshkin85

Vadim Koshkin MD

2 years

@ERPlimackMD @UCSFCancer Thank you Betsy for highlighting our work with @Tanjin097 @UCSFCancer @UCSFMedicine CRCs and research nurses are awesome and do high quality work. Unfortunately they do not have the opportunity to apply for @ASCO Merit awards which is something to hopefully change @montypal

0

2

12

1

2

15

@AmandaNizamMD

Amanda Nizam, MD

8 months

Excellent & timely Keynote from @ctleeuro : 🔷 Need to enrich for pt populations in trials w/similar or ⬆️ mortality compared to ref. White pop. 🔷 Diverse population of US allows unique opportunity for US sites to ⬆️ diversity in global clinical trials 🔷 @WalterStadler5 :

Tweet media one

Tweet media two

Tweet media three

Tweet media four

1

5

15

@AmandaNizamMD

Amanda Nizam, MD

3 years

Congratulations to Dr. @shilpaonc and team after many years of hard work on developing this trial of maintenance cabozantinib + avelumab in advanced bladder cancer! @CleClinicMD @ClevelandClinic @jamecancerdoc #guonc #blcsm

@tompowles1

Tom Powles

3 years

The MAINCAV randomised trial explores the addition of cabozantinib to avelumab as 1st line maintenance therapy in advanced bladder cancer. 650 patients required to show and OS advantage (primary endpoint). Congrats to Shilpa and the team. @shilpaonc

2

24

76

1

1

15

@AmandaNizamMD

Amanda Nizam, MD

7 months

Thanks to the amazing @ASCO team & all staff for another spectacular #GU24 !! We couldn’t do what we do without you! Safe travels to all & look forward to seeing you at #ASCO24 !! 😃

@AmandaBinDC

Amanda Narod

7 months

That's a wrap #GU24 ! 20 years! Wild to think I've been w @ASCO for the majority of them (obvi started working at 5yo 🫣🤣). It's an honor to support the brightest minds in cancer research. It's even sweeter when they become friends. Never feels like work when you're w friends 🫶

Tweet media one

1

9

37

0

2

15

@AmandaNizamMD

Amanda Nizam, MD

2 years

@esinghimd @ASCO @minasedrakmd @ADesaiMD @FawziAbuRous @drRTee @HemOncFellows @MadhuEluri @MDanmolsingh @GuoJin1 @ChrisCannMD @vpatelmd Great resource, indeed! Keep an eye out for our updated article on navigating the job search in this month’s @ASCO Connection! Thank you to the @ASCO team for the opportunity to contribute on behalf of the ASCO TECAG. @AnaVManana @ramsedhom @MazieTsangMD @ZaidAR_MD @ADesaiMD

1

1

15

@AmandaNizamMD

Amanda Nizam, MD

8 months

Congratulations & well deserved, @CYJiangMD !! A contemporary & practical sequencing❓in aUC! Check out her poster ⬇️ #GU24 #UNITE @PGrivasMDPhD @neerajaiims 📄 Abs. 616 / Poster G22 🔷 Poster Session B: Urothelial Ca 📆 Fri. 1/26/2024 ⏱️ 11:30am - 1:00pm PST 📍Level 1, West Hall

@OAlhalabiMD

Omar Alhalabi, MD

8 months

Congratulations to our rising fellow @CYJiangMD @MDAndersonNews for receiving the prestigious @ASCO @ConquerCancerFd merit award for the collaborative work the UNITE #bladdercancer group. She asked how to sequence therapy in FGFR altered dx. Be sure to stop by her poster #GU24

Tweet media one

Tweet media two

Tweet media three

0

7

41

0

6

14

@AmandaNizamMD

Amanda Nizam, MD

8 months

Anyone interested in #HRQOL & #toxicity should be following @crisbergerot ’s consistently outstanding work! Focusing on what is important & matters most to pts. Kudos also to @RCCadvocate for studying pt preferences in RCC & calling our attention to this! We must incorporate

@montypal

Sumanta K. Pal, MD, FASCO

8 months

Flashback to 2017 - the first @ASCO mtg I attended with @crisbergerot . Fast forward 7y later & she is a globally recognized expert in #HRQOL on the @ASCO #GU24 mainstage. In a project mentored by @tompowles1 w collaborators incl @ERPlimackMD @AlbigesL @DrChoueiri @virajmaster

Tweet media one

Tweet media two

Tweet media three

Tweet media four

4

22

94

1

7

15